Swiss National Bank’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-43,859
| Closed | -$787K | – | 2502 |
|
|
2017
Q4 | $787K | Hold |
43,859
| – | – | ﹤0.01% | 2225 |
|
|
2017
Q3 | $518K | Hold |
43,859
| – | – | ﹤0.01% | 2371 |
|
|
2017
Q2 | $461K | Buy |
43,859
+8,000
| +22% | +$81.5K | ﹤0.01% | 2426 |
|
|
2017
Q1 | $394K | Hold |
35,859
| – | – | ﹤0.01% | 2439 |
|
|
2016
Q4 | $486K | Hold |
35,859
| – | – | ﹤0.01% | 2407 |
|
|
2016
Q3 | $441K | Hold |
35,859
| – | – | ﹤0.01% | 2391 |
|
|
2016
Q2 | $393K | Hold |
35,859
| – | – | ﹤0.01% | 2454 |
|
|
2016
Q1 | $378K | Buy |
35,859
+6,900
| +24% | +$87.2K | ﹤0.01% | 2422 |
|
|
2015
Q4 | $501K | Hold |
28,959
| – | – | ﹤0.01% | 2262 |
|
|
2015
Q3 | $575K | Buy |
28,959
+9,659
| +50% | +$221K | ﹤0.01% | 2117 |
|
|
2015
Q2 | $317K | Hold |
19,300
| – | – | ﹤0.01% | 2439 |
|
|
2015
Q1 | $300K | Buy |
19,300
+4,700
| +32% | +$72.9K | ﹤0.01% | 2396 |
|
|
2014
Q4 | $208K | Hold |
14,600
| – | – | ﹤0.01% | 2494 |
|
|
2014
Q3 | $95K | Hold |
14,600
| – | – | ﹤0.01% | 2517 |
|
|
2014
Q2 | $101K | Buy |
14,600
+4,300
| +42% | +$30.4K | ﹤0.01% | 2529 |
|
|
2014
Q1 | $74K | Buy |
10,300
+1,700
| +20% | +$14.5K | ﹤0.01% | 2491 |
|
|
2013
Q4 | $81K | Hold |
8,600
| – | – | ﹤0.01% | 2491 |
|
|
2013
Q3 | $54K | Hold |
8,600
| – | – | ﹤0.01% | 2480 |
|
|
2013
Q2 | $57K | Buy |
+8,600
| New | +$68.2K | ﹤0.01% | 2497 |
|
Other funds holding SCMP
Swiss National Bank's SCMP Position: Q1 2018 in Review
Swiss National Bank sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 43,859 shares — an estimated $787K sold.
Swiss National Bank first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $787K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Swiss National Bank reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Swiss National Bank sold 43,859 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $787K.
- Swiss National Bank first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Swiss National Bank's Sucampo Pharmaceuticals, Inc. position peaked at $787K in Q4 2017.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Swiss National Bank's 13F filing for Q1 2018, filed 4 May 2018.